Brookfield Asset Management Inc. Bristol Myers Squibb CO Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	BUY	$63.71 - $70.74 $572,561 - $635,740	8,987 Added 93.46%	18,603 $1.19 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $572,561 - $635,740	8,987 Added 93.46%	18,603 $1.19 Million
Q1 2023 Sep 25, 2023	SELL	$65.71 - $74.53 $590,535 - $669,801	-8,987 Reduced 48.31%	9,616 $666,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $631,867 - $716,680	9,616 New	9,616 $666,000
Q2 2022 Nov 16, 2022	BUY	$72.62 - $79.98 $14.5 Million - $16 Million	199,994 New	199,994 $15.4 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $11.2 Million - $12.3 Million	153,715 Added 332.15%	199,994 $15.4 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $290,001 - $347,737	-4,717 Reduced 9.25%	46,279 $3.38 Million
Q2 2021 Aug 17, 2021	BUY	$61.91 - $67.42 $3.16 Million - $3.44 Million	50,996 New	50,996 $3.41 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.